- 专利标题： TRIFLUOROMETHYL PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF
-
申请号： US16123051申请日： 2018-09-06
-
公开(公告)号： US20190175556A1公开(公告)日： 2019-06-13
- 发明人: Alexander R. Hurd , Clarke B. Taylor , Jian Wang , Peng Zhou
- 申请人： Lycera Corporation
- 主分类号： A61K31/415
- IPC分类号： A61K31/415 ; A61K9/48 ; C07D231/38 ; A61K9/00 ; A61K9/28
摘要：
The invention provides trifluoromethyl pyrazolyl guanidine compounds that inhibit F1F0-ATPase, and methods of using trifluoromethyl pyrazolyl guanidine compounds as therapeutic agents to treat medical disorders, such as an immune disorder, inflammatory condition, or cancer.